Healthcare
Do the New Obesity Drugs Pay for Themselves?
Could expensive drugs like Ozempic save healthcare systems money by reducing the risk of obesity-associated diseases? A new study co-authored by Yale SOM’s Jason Abaluck suggests that other health expenses may actually increase over the first couple years of treatment.
Adapting Primary Care to a Pandemic
Dr. Frank Ciminiello ’19 explains how his medical practice has reconfigured to safely meet patients’ needs.
On COVID-19 Vaccines, Big Pharma Knows to Just Say ‘No’
In the face of pressure from President Donald Trump, nine major pharmaceutical companies have signed a pledge to complete testing before submitting vaccines for approval. Yale's Jeffrey Sonnenfeld and Dr. Albert Ko write that the drugmakers’ caution may help provide badly needed confidence in the eventual vaccine.
Choosing the Wrong Health Insurance Could Kill You
Yale SOM’s Jason Abaluck and his co-authors calculated that the Medicare Advantage plans appreciably influence the survival rates of their enrollees. Shutting down the plans with the highest mortality rates could save thousands of lives per year.
Repurposing with a Purpose
David Browning ’99 explains how a nonprofit doing coffee sustainability verification became a source of crucial public health data.
Three Questions about COVID-19 Infection and Immunity
We checked in with Yale SOM’s Dr. Howard Forman about herd immunity, vaccines, and that case of reinfection in Hong Kong.
Design, Test, Spread
Nicolas Encina ’10 and his colleagues at Ariadne Labs have been demonstrating the potential of a collaborative, multidisciplinary process for designing and scaling simple improvements to healthcare—and also its limits.
Smartphone Data Shows How Shared Staff Spread COVID-19 through Nursing Homes
COVID-19 infections have spread rapidly through nursing homes. A new study co-authored by Yale SOM’s Judith A. Chevalier finds one likely explanation: staff members who work at multiple nursing homes.
Buprenorphine Can Transform Treatment of Opioid Addiction, But It Isn’t Reaching Enough Patients
According to a new study co-authored by Yale SOM’s Marissa King, most patients aren’t staying on the drug long enough to get its benefit, and it isn’t reaching young people.
Study: Controlling COVID-19 Outbreaks in Residential Colleges Requires Frequent Testing
Using a computer model, the researchers found that weekly testing will keep outbreaks under control under relatively optimistic scenarios, but that testing every three days would be more reliable.
The Secret of Connecticut’s Success in Battling COVID-19
Prof. Edward Kaplan explains how Connecticut has dramatically reduced the rate of infection of COVID-19 in the state—and what risks still remain.
